氧化三甲胺在糖尿病中的研究进展

doi:10.3969/j.issn.1003-9198.2022.01.002

摘要/Abstract

中图分类号:

R 587.1

苑莉莉, 何峥. 氧化三甲胺在糖尿病中的研究进展[J]. 实用老年医学, 2022, 36(1): 2-5.

[1] International Diabetes Federation.IDF Diabetes Atlas[M]. 9th ed. Brussels: International Diabetes Federation, 2019.
[2] TOMASOVA L, KONOPELSKI P, UFNAL M. Gut bacteria and hydrogen sulfide: the new old players in circulatory system homeostasis[J]. Molecules, 2016, 21(11):1558.
[3] DAMBROVA M, LATKOVSKIS G, KUKA J, et al. Diabetes is associated with higher trimethylamine N-oxide plasma levels[J]. Exp Clin Endocrinol Diabetes,2016,124(4):251-256.
[4] ZHUANG R, GE X, HAN L, et al. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: a systematic review and dose-response meta-analysis[J]. Obes Rev, 2019, 20(6):883-894.
[5] SHAN Z, SUN T, HUANG H, et al. Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes[J]. Am J Clin Nutr, 2017,106(3):888-894.
[6] MOFFA S, MEZZA T, CEFALO C M A, et al. The interplay between immune system and microbiota in diabetes[J]. Mediators Inflamm, 2019, 2019:9367404.
[7] GAO X, LIU X, XU J, et al. Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet[J]. J Biosci Bioeng, 2014,118(4):476-481.
[8] ZHOU H, SUN L, ZHANG S, et al. Evaluating the causal role of gut microbiota in type 1 diabetes and its possible pathogenic mechanisms[J]. Front Endocrinol: Lausanne, 2020, 11:125.
[9] HASAIN Z, MOKHTAR N M, KAMARUDDIN N A, et al. Gut microbiota and gestational diabetes mellitus: a review of host-gut microbiota interactions and their therapeutic potential[J]. Front Cell Infect Microbiol, 2020, 10:188.
[10] SHARMA S, TRIPATHI P. Gut microbiome and type 2 diabetes: where we are and where to go?[J]. J Nutr Biochem, 2019, 63:101-108.
[11] HARMA M, LI Y, STOLL M L,et al. The epigenetic connection between the gut microbiome in obesity and diabetes[J]. Front Genet, 2019, 10:1329.
[12] YU P, GONG X, MENG Q,et al. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: a systematic review and dose-response meta-analysis[J]. Obes Rev, 2019, 20(6):883-894.
[13] ANDRAOS S, LANGE K, CLIFFORD S A, et al. Plasma trimethylamine N-oxide and its precursors: population epidemiology, parent-child concordance, and associations with reported dietary intake in 11- to 12-year-old children and their parents[J].Curr Dev Nutr, 2020, 4(7):nzaa103.
[14] SCHUGAR R, SHIH D M, WARRIER M,et al. The TMAO-producing enzyme flavin-containing monooxy-genase 3 regulates obesity and the beiging of white adipose tissue[J]. Cell Rep, 2017, 19(12):2451-2461.
[15] HEIANZA Y,SUN D,LI X, et al. Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial[J]. Gut, 2018, 68(2):263-270.
[16] KASSELMAN L, VERNICE N A, DELEON J A. The gut microbiome and elevated cardiovascular risk in obesity snd autoimmunity[J]. Atherosclerosis, 2018, 271(2):203-213.
[17] DÍAZ-RIZZOLO D A, KOSTOV B, LÓPEZ-SILES M,et al. Healthy dietary pattern and their corresponding gut microbiota profile are linked to a lower risk of type 2 diabetes, independent of the presence of obesity[J]. Clin Nutr, 2020, 39(2):524-532.
[18] ASCHER S, REINHARDT C. The gut microbiota: an emerging risk factor for cardiovascular and cerebrovascular disease[J]. Eur J Immunol, 2018, 48(4):564-575.
[19] SARAVANAN S. Trimethylamine oxide (TMAO): a new toxic kid on the block[J]. J Biomol Res Ther, 2018, 7(1):e159.
[20] HAM B, HWANG H B, JUNG S H,et al. Distribution and diversity of ocular microbial communities in diabetic patients compared with healthy subjects[J]. Curr Eye Res, 2018, 43(3):314-324.
[21] ST LEGER A J, CASPI R R. Visions of eye commensals: the known and the unknown about how the microbiome affects eye disease[J]. Bioessays, 2018, 40(11):e1800046.
[22] BELI E, YAN Y, MOLDOVAN L,et al. Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice[J]. Diabetes, 2018, 67(9):1867-1879.
[23] LUPACHYK S, WATCHO P, STAVNIICHUK R,et al. Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy[J]. Diabetes, 2013, 62(3):944-952.
[24] YU Z L, ZHANG L Y, JIANG X M, et al. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice[J]. J Food Sci, 2020, 85(7):2207-2215.
[25] ADACHI K, SUGIYAMA T, YAMAGUCHI Y, et al. Gut microbiota disorders cause type 2 diabetes mellitus and homeostatic disturbances in gut-related metabolism in Japanese subjects[J]. J Clin Biochem Nutr, 2019, 64(3):231-238.
[26] HALUZÍK M, MRÁZ M. Intermittent fasting and prevention of diabetic retinopathy: where do we go from here?[J]. Diabetes, 2018, 67(9):1745-1747.
[27] CHEN S, HENDERSON A, PETRIELLO M C, et al. Trimethylamine N-oxide binds and activates PERK to promote metabolic dysfunction[J]. Cell Metab, 2019, 30(6):1141-115.

氧化三甲胺在糖尿病中的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	王苏, 赵一璟, 魏晨敏, 陈堃, 曹雯, 王昆, 杨昱. 老年T2DM病人甘油三酯葡萄糖指数与低密度脂蛋白亚型的关系研究[J]. 实用老年医学, 2024, 38(10): 1002-1006.
[2]	顾崇怀, 项学军, 郑元喜, 乔锐, 林松. 达格列净对接受冠状动脉介入治疗的伴有射血分数降低的心力衰竭合并2型糖尿病老年病人疗效观察[J]. 实用老年医学, 2024, 38(10): 1025-1029.
[3]	周潇, 顾荣, 孔小岑, 罗勇, 王蔚萍, 马建华, 李惠琴. 桑枝总生物碱和卡格列净治疗血糖控制不佳的老年2型糖尿病病人的疗效观察[J]. 实用老年医学, 2024, 38(10): 1066-1069.
[4]	刘倩慧, 姚子俊, 何玉立, 徐云凡, 吴军. 老年2型糖尿病合并慢性心力衰竭病人HbA1c水平对心脏结构和功能的影响[J]. 实用老年医学, 2024, 38(5): 491-437.
[5]	刘童君, 赵雅洁, 胡洁玲, 胡洋, 梁伟. 糖代谢异常对血清激活素A水平的影响[J]. 实用老年医学, 2024, 38(5): 495-437.
[6]	杨龙璇, 唐伟. 细胞衰老与2型糖尿病胰岛B细胞功能障碍的研究进展[J]. 实用老年医学, 2024, 38(5): 521-437.
[7]	王金涛, 胡坚. 老年人2型糖尿病与肌少症的关系研究进展[J]. 实用老年医学, 2024, 38(5): 529-437.
[8]	唐源, 邓暑芳, 何咏梅, 戴雨璇, 罗晶. 老年2型糖尿病病人健康素养水平及其与衰弱的相关性[J]. 实用老年医学, 2024, 38(3): 255-259.
[9]	代玲俐, 俞匀. 老年2型糖尿病病人估计肾小球滤过率与胰岛素抵抗及胰岛B细胞功能的相关性研究[J]. 实用老年医学, 2023, 37(12): 1219-1223.
[10]	范婷泳, 袁丽, 杨小玲, 陈茜. Caprini量表评估老年糖尿病病人静脉血栓栓塞症的效果[J]. 实用老年医学, 2023, 37(12): 1233-1237.
[11]	张贺成, 魏苏. 老年2型糖尿病病人血清铁蛋白水平与糖尿病足发生的相关性[J]. 实用老年医学, 2023, 37(11): 1111-1114.
[12]	胡艳, 巫海娣, 王雪菲, 娄青林, 叶青, 顾刘宝, 戴静, 宋小波. 老年2型糖尿病病人糖尿病足风险评分与尿微量白蛋白/肌酐的相关性分析[J]. 实用老年医学, 2023, 37(11): 1134-1137.
[13]	宗前兴, 莫永珍. 老年2型糖尿病健康状态分层框架的应用与研究进展[J]. 实用老年医学, 2023, 37(11): 1170-1175.
[14]	张林英, 梅群超, 张炜琦, 胡一兰. 抗阻训练联合高乳蛋白营养在老年2型糖尿病伴肌少症病人中的应用研究[J]. 实用老年医学, 2023, 37(10): 995-999.
[15]	刘倩慧, 姚子俊, 何玉立, 吴军. SGLT2i对老年糖尿病病人心血管保护机制的研究进展[J]. 实用老年医学, 2023, 37(10): 1064-1068.